Why Cervical
Cancer
A disease we already know how to stop continues to claim nearly one thousand lives every day. The failure is systemic, not scientific.
Cervical cancer is the clearest possible test—and a deliberate starting point.
Few conditions present such a stark paradox. Cervical cancer is preventable through vaccination and screening, yet it continues to kill nearly one thousand women every day.
The overwhelming majority of these deaths occur in low- and middle-income countries, where access to even the most basic preventive services remains limited. What we are witnessing is a systemic failure—one that persists despite the tools to address it already being in hand.
“Cervical cancer functions as a diagnostic lens on global health itself—revealing, with unusual clarity, where systems succeed, where they fail, and who is left behind.”
The ultimate disease of inequality.
Cervical cancer disproportionately affects women in settings where healthcare access is weakest and where social and economic structures often undervalue women’s lives.
The persistence of a preventable cancer at this scale raises a deeper question: what does it mean when a disease we already know how to stop continues to claim lives with so little global urgency?
“Eliminating cervical cancer carries a dual significance: it is at once a technical achievement and a declaration that the lives of women and girls are central to the story of development.”
Preventable. Yet persistent.
The biology and natural history of cervical cancer make its continued burden all the more striking. Most HPV infections clear spontaneously. Vaccines exist. Organised screening programs have already reduced incidence dramatically in countries that have sustained them.
What We Have
Prevention & Cure Exist
Vaccines can prevent the majority of high-risk HPV infections. Early-stage disease is highly curable. Organised screening has already slashed incidence in countries that sustained it. The scientific basis is well established.
What We Face
Silent Progression
High-grade precancerous changes produce no symptoms. Infection is common across the lifespan. In immunocompromised populations, persistence becomes far more likely—making absence of systems lethal.
The Consequence
Detection Without Treatment
By the time many women present for care in resource-limited settings, the disease is already advanced. Detection without treatment amounts to deferred tragedy.
The primary gap lies in delivery,
not in knowledge.
The global community has already outlined a path to elimination. The World Health Organization’s 90–70–90 strategy provides a clear and achievable framework: 90% of girls vaccinated against HPV, 70% of women screened for cervical disease, and 90% of women with identified disease receiving treatment.
But the final step, treatment of identified disease, depends on something far more difficult to scale: infrastructure.
Comprehensive cancer centres—facilities capable of delivering diagnosis, surgery, radiotherapy, and coordinated care—remain critically scarce in the regions where cervical cancer is most prevalent. Without them, screening cannot translate into survival.
“This is where the system breaks—at the level of delivery, where knowledge alone cannot reach.”
Cervical cancer is the pattern.
What one disease reveals in concentrated form, cancer as a whole expresses at scale.
A microcosm of a much larger reality.
people expected to develop cancer in their lifetime
nearly 1,000 deaths per day from cervical cancer alone
of cervical cancer deaths occur in low- and middle-income countries
of the global cancer burden preventable with existing knowledge
Cancer accounts for a substantial proportion of global mortality, yet its burden is distributed unevenly. The majority of deaths occur in developing countries, where only a small fraction of global cancer resources are allocated.
Across settings, the pattern is strikingly consistent: late presentation, limited access to diagnostics, fragmented treatment pathways, and financial catastrophe for patients and families. A global system oriented too late in the course of disease.
Beyond clinical outcomes.
The impact of cancer extends far beyond the clinic. It is one of the most profound sources of human and economic disruption worldwide—deepening inequality and limiting development in ways that compound across generations.
For Individuals & Families
A diagnosis reverberates through families, often exhausting savings, interrupting education, and reshaping livelihoods. In many settings, medical expenses become a primary driver of poverty.
For Nations & Systems
At the national level, the cumulative burden places sustained pressure on health systems and economic growth. Cancer is a medical, social, and economic force—one that shapes development outcomes at every level.
Despite its scale, cancer is not intractable.
A significant proportion of the global burden can already be addressed with existing knowledge. And cervical cancer goes further still—it stands as one of the few cancers that can be eliminated as a public health problem.
Preventable
Roughly one third of cancers can be prevented through risk reduction and vaccination—with tools available today.
Treatable Early
Another third can be effectively treated if detected early, before the disease advances beyond the reach of available interventions.
Impact on Quality of Life
Even in advanced disease, palliative care can substantially improve quality of life—reducing suffering at every stage.
From responding to illness,
to preventing it.
The persistence of preventable disease points to a deeper structural issue. Modern healthcare systems are overwhelmingly designed to respond to illness after it appears, rather than to anticipate and prevent it.
Preemptology represents a deliberate shift in this orientation—the systematic practice of identifying risk early, intervening before disease develops, and embedding prevention across all levels of care.
“At its core is a new kind of physician—the preemptologist—trained to stop disease before it begins, rather than solely to treat it once it has.”
This approach is both clinically effective and economically transformative. Prevention is typically far less costly than treatment, and its benefits compound across populations and over time.
The operational heart of an integrated system—
and a comprehensive treatment facility at its centre.
Within the preemptology model, the Comprehensive Cancer Centre connects community-based prevention with advanced care—and serves as a platform for training, research, and system coordination.
Translates screening into survival by closing the gap between detection and treatment
Provides the infrastructure for diagnosis, surgery, radiotherapy, and coordinated care under one system
Anchors a shift from reactive to proactive medicine—serving as a training hub and research platform
Enables elimination of cervical cancer—and extends the same integrated model to all cancers
Cervical cancer is the starting point.
The destination is a world in which preventable
disease is no longer allowed to persist.
If one cancer can be eliminated through coordinated prevention, early detection, and system-level investment, the same principles can be applied more broadly. The capability exists. The remaining question is whether we will act.